Bio-Techne Corporation, in collaboration with ScaleReady, Wilson Wolf Manufacturing, and CellReady, has announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant. This funding is part of a broader initiative aimed at enhancing the scalability and cost-effectiveness of CAR-T cell manufacturing in India. The grant will support Immuneel's process development, validation, and comparability studies at their state-of-the-art GMP facility in Bengaluru. This initiative is part of ScaleReady's G-Rex Grant Program, which has increased its total award funds to $30 million. The program has already awarded 200 grants, with each recipient eligible for up to $300,000 and access to exclusive support from a consortium of G-Rex Grant Partners.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。